Assisted reproductive technology (ART) refers to fertility treatments and procedures that involve the manipulation of eggs, sperm or embryos to increase the likelihood of a successful pregnancy in humans. ART includes all fertility treatments in which either the eggs or the embryos are handled.
The assisted reproductive technology (ART) market consists of sales, by entities (organizations, sole traders and partnerships), of assisted reproductive technology (ART) procedures that are used for the treatment of infertility.
The global assisted reproductive technology (ART) market was valued at $28,624.0 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.
Increasing Prevalence Of PCOS
The high prevalence of PCOS (polycystic ovary syndrome) condition supported the assisted reproductive technology market growth in the historic period. PCOS is a hormonal disorder that occurs in women of reproductive age. It is the most common endocrine (hormone) disorder in reproductive-age people with ovaries, affecting, conservatively, 5-10% of that population. ART offers tailored treatment options for individuals with PCOS, addressing the specific reproductive challenges associated with the condition and increasing the likelihood of successful conception and pregnancy. IVF is a more advanced ART procedure that involves the retrieval of eggs from the ovaries, fertilization with sperm in a laboratory setting, and transferring resulting embryos into the uterus. PCOS is one of the leading causes of female infertility, responsible for an estimated 80% of "anovulatory" (no ovulation) infertility cases. IVF is one of the most common treatments for women to increase fertility in women with PCOS. Furthermore, according to WHO, a Switzerland-based specialized agency, approximately 116 million women (3.4%) are affected by PCOS globally. Therefore, increased cases of PCOS drove the assisted reproductive technology market growth in the historic period.
Impact Of Artificial Intelligence On Assisted Reproductive Technology
Several key players operating in the assisted reproductive technology market are integrating efforts to introduce technological innovations, such as artificial intelligence (AI) software, to advance IVF treatment outcomes and lower the costs of the treatment. In IVF, AI algorithms analyze vast amounts of data from patient medical records, lab tests and imaging studies to identify patterns and make predictions. For instance, in October 2022, Alife, a US-based AI-based health technology firm, launched new artificial intelligence software to help fertility clinics optimize and support clinical decision-making during critical stages of the IVF process. Alife uses AI and significant U.S. IVF data sets to examine millions of patient cycle data points. The company's technology can help optimize the IVF treatment process from start to finish by reducing clinic operations and giving patients a more tailored experience.
The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022.
Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Technology: In Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
- 2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
- 3) By End-User: Hospitals; Fertility Clinics; Other End-Users
- 4) By Testing/Diagnosis: In Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests
- Companies Mentioned: Vitrolife; Ferring B.V.; Progyny Inc.; CooperSurgical Inc.; FUJIFILM Irvine Scientific, Inc.
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.